Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer
PaperCitations, authors & open-access status
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 627 citations, 2018 year and hybrid oa status.
627
Citations
2018
Year
hybrid
OA Status